2024/08/07 08:40:11 | |
---|---|
Price | |
41.28 EUR | |
Difference | 0.15% (0.06) |
ISIN | DE0005659700 |
Symbol | EUZ |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 855 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 41.28 EUR (261) |
Ask (Ask size) | 41.58 EUR (520) |
Open | 41.58 EUR |
High | 41.58 EUR |
Low | 41.28 EUR |
Close (prev. day) | 41.22 EUR |
VWAP | - |
Volume (pcs) | 520 |
Trading volume | 21,621.60 |
Number of trades | 7 |
Last size | 0 |
Related Futures | - |
Related Options | 649 |
Date | Headline | Download | |
2024/07/24 | Global Equity Ratings | ||
2024/07/12 | Global Equity Ratings | ||
2024/06/21 | Global Equity Ratings | ||
2024/06/14 | Global Equity Ratings | ||
2024/05/29 | Global Equity Ratings |
2024/08/07 08:40:11 | |
---|---|
Price | |
41.28 EUR | |
Difference | 0.15% (0.06) |
ISIN | DE0005659700 |
Symbol | EUZ |
Exchange | Stuttgart |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 855 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | 41.28 EUR (261) |
Ask (Ask size) | 41.58 EUR (520) |
Open | 41.58 EUR |
High | 41.58 EUR |
Low | 41.28 EUR |
Close (prev. day) | 41.22 EUR |
VWAP | - |
Volume (pcs) | 520 |
Trading volume | 21,621.60 |
Number of trades | 7 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -7.70% | +24.23% | -66.57% |
Perf (abs.) | -3.44 | +8.04 | -82.08 |
Beta | 1.09 | 1.29 | 1.45 |
Volatility | 47.66 | 44.31 | 49.48 |
Ø price 5 days | Ø volume 5 days (pcs.) | 41.52 EUR (1,421) |
Ø price 30 days | Ø volume 30 days (pcs.) | 44.58 EUR (1,042) |
Ø price 100 days | Ø volume 100 days (pcs.) | 42.07 EUR (1,447) |
Ø price 250 days | Ø volume 250 days (pcs.) | 39.28 EUR (1,482) |
YTD High | date | 49.94 EUR (2024/07/16) |
YTD Low | date | 32.62 EUR (2024/04/19) |
52 Weeks High | date | 49.94 EUR (2024/07/16) |
52 Weeks Low | date | 29.02 EUR (2023/09/25) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Berlin | 2024/08/07 | 08:11 | 41.42 EUR | 0.00 | 1 |
Duesseldorf | 2024/08/07 | 08:10 | 41.28 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/08/06 | 17:44 | 40.86 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | 2024/08/06 | 17:44 | 40.86 EUR | 0.00 | 1 |
Frankfurt | 2024/08/07 | 08:01 | 41.14 EUR | 0.00 | 1 |
Hamburg | 2024/08/07 | 08:12 | 41.28 EUR | 0.01 | 1 |
Hanover | 2024/08/07 | 08:16 | 41.14 EUR | 0.00 | 1 |
London Stock Exchange European Trade Reporting | 2024/08/06 | 17:30 | 40.61 EUR | 0.00 | 2 |
Munich | 2024/08/07 | 08:02 | 41.14 EUR | 0.00 | 1 |
Stuttgart | 2024/08/07 | 08:40 | 41.28 EUR | 0.02 | 7 |
Tradegate | 2024/08/07 | 08:43 | 41.28 EUR | 0.02 | 7 |
Xetra | 2024/08/06 | 17:36 | 41.00 EUR | 1.17 | 415 |
ECKERT & ZIEGLER SE |
- - |
Robert-Rössle-Strasse 10 - 13125 Berlin |
Telefon: +49-30-94-10-84-0 |
Fax: +49-30-94-10-84-112 |
E-mail: info@ezag.de |
Eckert & Ziegler SE is a holding company, which engages in the processing of radio isotopes. It also focuses on the development, production, and sale of isotope technology components and related products. It operates through the following segments: Isotope Products, Medical, and Other. The Isotope Products segment manufactures and distributes standards, and radiation sources for medical and industrial purposes. The Medical segment offers small radioactive implants for treating prostate cancer and eye applications for treating uveal melanoma. The Other segment focuses pools internal group services like radiation protection, legal, accounting, information technology, and human resources. The company was founded by Andreas Eckert in 1997 and is headquartered in Berlin, Germany. |
Harald Hasselmann | Chairman of Managing Board |
Franklin Yeager | Member of Executive Committee |
Jutta Ludwig | Member of Executive Committee |
Andreas Eckert | Chairman of Supervisory Board |
Edgar Löffler | Member of Supervisory Board |
Helmut Grothe | Member of Supervisory Board |
Albert Rupprecht | Member of Supervisory Board |
Frank Perschmann | Member of Supervisory Board |
Paola Eckert-Palvarini | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer